Tafenoquine for children: a step towards implementation

Tafenoquine for children: a step towards implementation

Detaylı Bibliyografya
Asıl Yazarlar:	Commons, RJ, Price, RN
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2021

Benzer Materyaller

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
Yazar:: Commons, RJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
Yazar:: Watson, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
Yazar:: Watson, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Tafenoquine — a radical improvement?
Yazar:: White, N
Baskı/Yayın Bilgisi: (2019)

The antimalarial activity of tafenoquine in falciparum malaria
Yazar:: White, NJ
Baskı/Yayın Bilgisi: (2023)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
Yazar:: Geoffrey W. Birrell, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
Yazar:: Watson, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
Yazar:: Baird, J
Baskı/Yayın Bilgisi: (2018)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
Yazar:: Pengfei She, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
Yazar:: James A Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Yazar:: James A Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Tafenoquine and G6PD: a primer for clinicians
Yazar:: Chu, CS, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Yazar:: James A Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
Yazar:: St Jean, PL, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
Yazar:: Watson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
Yazar:: Llanos-Cuentas, A, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
Yazar:: Lacerda, MVG, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
Yazar:: Luisa Oliveira Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
Yazar:: Baird, JK
Baskı/Yayın Bilgisi: (2021)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
Yazar:: Stephan Duparc, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
Yazar:: Römsing, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
Yazar:: Romsing, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
Yazar:: Watson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Yazar:: James Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
Yazar:: Raman Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)
Yazar:: Alicia P. C. Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Yazar:: Ebstie YA, ve diğerleri
Baskı/Yayın Bilgisi: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
Yazar:: Amit Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
Yazar:: Markus MB
Baskı/Yayın Bilgisi: (2021-09-01)

Estimating the proportion of plasmodium vivax recurrences caused by relapse: A systematic review and meta-analysis
Yazar:: Commons, RJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study)
Yazar:: Alicia Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Plasmodium vivax in the era of the shrinking P. falciparum map
Yazar:: Price, RN, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
Yazar:: Leonardo J. M. Carvalho, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
Yazar:: Christensen, Peter, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
Yazar:: Luis A. Marcos, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
Yazar:: Kenworthy David, ve diğerleri
Baskı/Yayın Bilgisi: (2011-07-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
Yazar:: Karen Kemirembe, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
Yazar:: Zeid A. ALOthman, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Yazar:: Raman Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Yazar:: Hale, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)